Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-25-061182
Filing Date
2025-06-20
Accepted
2025-06-20 16:28:11
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 tm2518361d1_424b5.htm 424B5 434743
2 GRAPHIC tm2518361d1_424b5img001.jpg GRAPHIC 11661
3 GRAPHIC tm2518361d1_424b5img002.jpg GRAPHIC 119463
4 GRAPHIC tm2518361d1_424b5img003.jpg GRAPHIC 118468
  Complete submission text file 0001104659-25-061182.txt   780318
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Theriva Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-279077 | Film No.: 251061789
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)